15 Results

People

  1. Carver
    Carver
  2. Sawyers
    Sawyers
  3. Adusumilli
    Adusumilli
  4. Sadelain
    Sadelain
  5. Colovos
    Colovos
  6. Hieronymus
    Hieronymus
  7. Servais
    Servais
  8. Bograd
    Bograd
  9. Chen
    Chen
  10. Wongvipat
    Wongvipat

Groups

  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. GSK Faculty (15)
  4. Hematologic Malignancies, Division of (15)
  5. Sloan Kettering Institute Faculty (15)
  6. Surgery (15)
  7. Molecular Pharmacology and Chemistry Program Faculty (11)
  8. Executive Committee, Center for Hematologic Malignancies (9)
  9. Human Oncology and Pathogenesis Program (9)
  10. Sloan Kettering Institute Postdocs (9)
  1. "Center for Hematologic Malignancies"
  2. "Department of Medicine"
  3. "GSK Faculty"
  4. "Sloan Kettering Institute Faculty"
  5. "Surgery"
  6. "nonhuman"
  7. "Journal article"
Formats
  1. Journal Article (15)
Groups
  1. Center for Hematologic Malignancies (15)
  2. Department of Medicine (15)
  3. GSK Faculty (15)
  4. Hematologic Malignancies, Division of (15)
  5. Sloan Kettering Institute Faculty (15)
  6. Surgery (15)

More Groups

People
  1. Brett Carver (8)
  2. Charles Sawyers (8)
  3. Prasad Adusumilli (7)
  4. John Wongvipat (6)
  5. Michel Sadelain (6)
  6. Christos Colovos (5)

More People

Years
  1. 2020 (2)
  2. 2015 (3)
  3. 2014 (3)
  4. 2012 (1)
  5. 2011 (5)
  6. 2009 (1)
Publications
  1. Cancer Cell (3)
  2. Clinical Cancer Research (2)
  3. PLoS ONE (2)
  4. Cancer Immunology, Immunotherapy (1)
  5. Cancer Research (1)
  6. Cell (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Cell Press (4)
  3. Nature Publishing Group (2)
  4. Public Library of Science (2)
  5. Springer (2)
  6. American Association for the Advancement of Science (1)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
    Journal Article

    Zhang, Z.; Karthaus, W. R.; Lee, Y. S.; Gao, V. R.; Wu, C.; Russo, J. W.; Liu, M.; Mota, J. M.; Abida, W.; Linton, E.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Oncogenic ERG represses PI3K signaling through downregulation of IRS2
    Journal Article

    Mao, N.; Gao, D.; Hu, W.; Gadal, S.; Hieronymus, H.; Wang, S.; Lee, Y. S.; Sullivan, P.; Zhang, Z.; Choi, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
    Journal Article

    Schwartz, S.; Wongvipat, J.; Trigwell, C. B.; Hancox, U.; Carver, B. S.; Rodrik-Outmezguine, V. ; Will, M.; Yellen, P.; de Stanchina, E.; Baselga, J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling
    Journal Article

    Wanjala, J.; Taylor, B. S.; Chapinski, C.; Hieronymus, H.; Wongvipat, J.; Chen, Y.; Nanjangud, G. J.; Schultz, N.; Xie, Y.; Liu, S.; more...
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
    Journal Article

    Adusumilli, P. S.; Cherkassky, L.; Villena-Vargas, J.; Colovos, C.; Servais, E.; Plotkin, J.; Jones, D. R.; Sadelain, M.
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Organoid cultures derived from patients with advanced prostate cancer
    Journal Article

    Gao, D.; Vela, I.; Sboner, A.; Iaquinta, P. J.; Karthaus, W. R.; Gopalan, A.; Dowling, C.; Wanjala, J. N.; Undvall, E. A.; Arora, V. K.; more...
    Cell (2014)

    Fulltext@MSK | Save
  • Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma
    Journal Article

    Kachala, S. S.; Bograd, A. J.; Villena-Vargas, J.; Suzuki, K.; Servais, E. L.; Kadota, K.; Chou, J.; Sima, C. S.; Vertes, E.; Rusch, V. W.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients
    Journal Article

    Servais, E. L.; Colovos, C.; Rodriguez, L.; Bograd, A. J.; Nitadori, J. I.; Sima, C.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
    Journal Article

    Bograd, A. J.; Suzuki, K.; Vertes, E.; Colovos, C.; Morales, E. A.; Sadelain, M.; Adusumilli, P. S.
    Cancer Immunology, Immunotherapy (2011)

    Fulltext@MSK | Save